SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-16-464729
Filing Date
2016-02-16
Accepted
2016-02-16 14:00:30
Documents
1
Group Members
MEDIMMUNE VENTURES, INC.

Document Format Files

Seq Description Document Type Size
1 SC 13G d133481dsc13g.htm SC 13G 57983
  Complete submission text file 0001193125-16-464729.txt   59653
Mailing Address 2 KINGDOM STREET - LEGAL DEPARTMENT LONDON X0 W2 6BD
Business Address 2 KINGDOM STREET - LEGAL DEPARTMENT LONDON X0 W2 6BD 011 44 20 7304 5000
ASTRAZENECA PLC (Filed by) CIK: 0000901832 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations

Mailing Address 91 HARTWELL AVE 2ND FLOOR LEXINGTON MA 02421
Business Address 91 HARTWELL AVE 2ND FLOOR LEXINGTON MA 02421 781-676-2100
INOTEK PHARMACEUTICALS CORP (Subject) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88750 | Film No.: 161426299
SIC: 2834 Pharmaceutical Preparations